Allosteric coupling between PIP <sub>2</sub> and Ca <sup>2+</sup> binding sites gates TMEM16A channels

J Jie Xu A Ana Santa-Cruz (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) A Aishwarya Chandrashekar (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) T Takeharu Kawano (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) R R. Charles Kissell (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) M Mehreen Zaka (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) Z Zhe Zhang M Meng Cui (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) D Diomedes E. Logothetis (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University) L Leigh D. Plant (Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University)

Abstract

TMEM16A channels conduct Ca 2+ -activated Cl − currents that underlie essential physiological processes including epithelial secretion, smooth muscle contraction, and sensory transduction. Channel activation requires both intracellular Ca 2+ and the signaling phospholipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ), yet the molecular basis of this dual regulation has remained unclear. Using gating molecular-dynamics simulations and structure-guided electrophysiology, we show that PIP 2 and Ca 2+ cooperatively gate TMEM16A through an allosterically coupled electrostatic network centered on the α4 helix. Specific PIP 2 headgroup phosphate interactions are essential for coupling Ca 2+ binding to channel opening, while the PIP 2 acyl chains engage hydrophobic surfaces of the helix to stabilize the open conformation. Disrupting either component of this lipid–protein interface reduces apparent PIP 2 affinity and impairs activation, whereas long-chain PIP 2 fully restores wild-type activity. These interactions act in concert with Ca 2+ -dependent structural rearrangements that widen the conduction pathway and enable Cl − permeation. Our findings establish that both the headgroup phosphates and acyl chains of PIP 2 play indispensable and complementary roles in TMEM16A gating. This mechanism defines a cooperative lipid–ion activation process that provides a general framework for understanding phosphoinositide regulation of ion channels and offers opportunities for structure-based design of TMEM16A modulators.

Article Details

Volume / Issue Vol. 123, Issue 7
Published February 17, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

J

Jie Xu

A

Ana Santa-Cruz

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

A

Aishwarya Chandrashekar

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

T

Takeharu Kawano

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

R

R. Charles Kissell

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

M

Mehreen Zaka

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

Z

Zhe Zhang

M

Meng Cui

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

D

Diomedes E. Logothetis

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University

L

Leigh D. Plant

Department of Pharmaceutical Sciences, Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Science, Northeastern University